Palantir is set to surge after a consolidation period. How to trade it while defining risk
Jeff Kilburg looks at Palantir after a rangebound period for the stock.
Uncategorized
There’s a record disconnect unfolding in the trading pits right now
The volatility spread between single stocks and the index makes a world of a difference for options traders.
There’s a record disconnect unfolding in the trading pits right now Read More »
Snowflake just had its best day ever. HSBC thinks there’s more to go
The bank upgraded the cloud computing name to buy from hold.
Snowflake just had its best day ever. HSBC thinks there’s more to go Read More »
This medtech name on Josh Brown’s list is hitting the sweet spot for momentum
Josh Brown and Sean Russo break down the fundamentals and technicals of this stock.
This medtech name on Josh Brown’s list is hitting the sweet spot for momentum Read More »
AI play Nebius is surging after mysterious new hedge fund manager reveals stake. Here are his other holdings
The fund invests in publicly traded companies expected to benefit from AI adoption — including semiconductor, infrastructure and power firms.
Mike Khouw: I was wrong about Zscaler. Here’s how I’m managing the trade
Khouw’s thesis this week for a bearish-to-bullish reversal rested on the idea that ZS had been unfairly punished.
Mike Khouw: I was wrong about Zscaler. Here’s how I’m managing the trade Read More »
Unusual Machines and other drone stocks surge on report Pentagon considering stakes in the industry
Drone stocks surged Thursday on a report the Trump administration is in talks to fund several firms, including one in which Donald Trump Jr. is a shareholder.
This biotech is leading what could be a ‘GLP-1 moment for hair loss,’ says BTIG
BTIG initiated research coverage with a buy rating, calling the biotech’s experimental hair loss treatment a possible ‘GLP-1 moment.’
This biotech is leading what could be a ‘GLP-1 moment for hair loss,’ says BTIG Read More »
Hedge funds loved Micron ahead of its run to $1 trillion. Here are their other favorite stocks
The Goldman Sachs VIP basket has outperformed the S&P 500 this year, through last Friday.
Insurance companies are buying back their own stock in hordes. Maybe they shouldn’t
Insurers are revisiting an old playbook from past down cycles, repurchasing stock to prop up earnings per share by shrinking the share count.
Insurance companies are buying back their own stock in hordes. Maybe they shouldn’t Read More »